...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AACR virtual meeting June22nd

This AACR poster is pre-clinical lab work. As far as I can tell, no additional clinical trial has been initiated.

BDAZ

Share
New Message
Please login to post a reply